Literature DB >> 10574836

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed.

W Tarnow-Mordi, A Mitra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10574836      PMCID： PMC1117123          DOI： 10.1136/bmj.319.7222.1385

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Evidence in perinatal medicine: enough of trial and error?

Authors:  D Field
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

2.  Gains and losses from dexamethasone for neonatal chronic lung disease.

Authors:  A Greenough
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

3.  Randomised controlled trials in perinatal medicine: 3. Identifying and measuring endpoints in randomised controlled trials.

Authors:  A Johnson
Journal:  Br J Obstet Gynaecol       Date:  1997-07

4.  Early dexamethasone therapy in preterm infants: a follow-up study.

Authors:  T F Yeh; Y J Lin; C C Huang; Y J Chen; C H Lin; H C Lin; W S Hsieh; Y J Lien
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

5.  Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

Authors:  T M O'Shea; J M Kothadia; K L Klinepeter; D J Goldstein; B G Jackson; R G Weaver; R G Dillard
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

Review 6.  Clinical trials of postnatal corticosteroids: inhaled and systemic.

Authors:  H L Halliday
Journal:  Biol Neonate       Date:  1999-06
  6 in total
  8 in total

1.  More trials on early treatment with corticosteroids are needed.

Authors:  N V Subhedar; A J Bennett; S P Wardle; N J Shaw
Journal:  BMJ       Date:  2000-04-01

2.  Investigating allegations of research misconduct. Worst outcome of Griffiths report would be that research becomes increasingly difficult.

Authors:  T Stephenson
Journal:  BMJ       Date:  2000-11-25

3.  Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease.

Authors:  D L Armstrong; J Penrice; F H Bloomfield; D B Knight; J A Dezoete; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

4.  Stopping the swinging pendulum of postnatal corticosteroid use.

Authors:  Sara B Demauro; Kevin Dysart; Haresh Kirpalani
Journal:  J Pediatr       Date:  2014-01       Impact factor: 4.406

Review 5.  Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-11-11

Review 6.  Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-10-21

Review 7.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Richard A Ehrenkranz; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2017-10-24

8.  Development of salivary cortisol circadian rhythm in preterm infants.

Authors:  Katrin Ivars; Nina Nelson; Annette Theodorsson; Elvar Theodorsson; Jakob O Ström; Evalotte Mörelius
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.